Merck & Co., Inc. is 230.8x more valuable than MARAVAI LIFESCIENCES HOLDINGS, INC. by market capitalization ($293.16 B vs $1.27 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MRVI | MRK |
|---|---|---|
| Market cap | $1.27 B | $293.16 B |
| US-listed rank | #2462 | #44 |
| Revenue (latest FY) | $185.74M | $65.01B |
| Net income (latest FY) | -$130.80M | $18.25B |
| Net margin | -70.4% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 393 | 996 |
Merck & Co., Inc. is 230.8x more valuable than MARAVAI LIFESCIENCES HOLDINGS, INC. by market capitalization ($293.16 B vs $1.27 B).
In their latest fiscal years, MARAVAI LIFESCIENCES HOLDINGS, INC. reported $185.74M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: MARAVAI LIFESCIENCES HOLDINGS, INC. and Merck & Co., Inc., or browse the full rankings.